MedTrace Logo

Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas

NCT01147601 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2017-07-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to learn about a new potential use for topical timolol 0.5% aqueous solution that may help treat small uncomplicated infantile hemangiomas. This study would examine whether topical timolol could be a potential therapy.

Conditions

  • Hemangioma
  • Infant

Interventions

DRUG

topical 0.5% Timolol

topical 0.5% Timolol aqueous solution, 2-3 drops to cover the hemangioma, twice daily

DRUG

Control (placebo) group

Control (placebo) group

Sponsors & Collaborators

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Alfons L. Krol, M.D. · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
8 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-10-31
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01147601 on ClinicalTrials.gov